These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4984791)

  • 1. Possible new concepts relating prostaglandins to various ocular functions.
    Waitzman MB
    Surv Ophthalmol; 1970 Jan; 14(4):301-26. PubMed ID: 4984791
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandins in ocular pathophysiology with special reference to diabetic retinopathy and glaucoma.
    Waitzman MB; Colley AM
    Metab Pediatr Syst Ophthalmol; 1983; 7(1):7-23. PubMed ID: 6353134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins and inflammatory reactions in the eye.
    Bhattacherjee P
    Methods Find Exp Clin Pharmacol; 1980 Feb; 2(1):17-31. PubMed ID: 6803089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The eye and its disorders. 6. The intra-ocular fluids.
    Trevor-Roper PD
    Int Ophthalmol Clin; 1974; 14(1-2):91-104. PubMed ID: 4420429
    [No Abstract]   [Full Text] [Related]  

  • 5. Degeneration release of norepinephrine causes transient ocular hyperemia mediated by prostaglandins.
    Neufeld AH; Chavis RM; Sears ML
    Invest Ophthalmol; 1973 Mar; 12(3):167-75. PubMed ID: 4692259
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins and the eye.
    Perkins ES
    Adv Ophthalmol; 1975; 29():2-21. PubMed ID: 1130238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pupil size and ocular pressure after sympathectomy and prostaglandin-catecholamine treatment.
    Waitzman MB
    Exp Eye Res; 1970 Oct; 10(2):219-22. PubMed ID: 4991874
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
    Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins and the eye: rapid transition from basic to applied and implications for expanded clinical consideration.
    Waitzman MB
    Metab Pediatr Syst Ophthalmol; 1982; 6(1):17-26. PubMed ID: 7132723
    [No Abstract]   [Full Text] [Related]  

  • 10. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
    Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release and effects of prostaglandins in ocular tissues.
    Abdel-Latif AA
    Prostaglandins Leukot Essent Fatty Acids; 1991 Oct; 44(2):71-82. PubMed ID: 1745655
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
    Bergman PB; Moravski CJ; Edmondson SR; Russo VC; Bach LA; Wilkinson-Berka JL; Werther GA
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2708-15. PubMed ID: 16043842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental investigations of intraocular eicosanoids: cultured human trabecular cells and laser photocoagulation of the rabbit iris.
    Weinreb RN; Mitchell MD
    Curr Eye Res; 1985 Mar; 4(3):281-90. PubMed ID: 4017626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensual ocular hypertensive response to prostaglandin.
    Chiang TS; Thomas RP
    Invest Ophthalmol; 1972 Mar; 11(3):169-76. PubMed ID: 4622275
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction.
    Oomen PH; Kant GD; Dullaart RP; Reitsma WD; Smit AJ
    Microvasc Res; 2002 Jan; 63(1):1-9. PubMed ID: 11749067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoids and thromboxane A2 involvement in diabetic retinopathy.
    Naveh-Floman N; Moisseiev J
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):321-5. PubMed ID: 6764248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.
    Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
    Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular changes in the anterior uvea of the rabbit produced by prostaglandins.
    Whitelocke RA; Eakins KE
    Arch Ophthalmol; 1973 Jun; 89(6):495-9. PubMed ID: 4196290
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic changes of prostaglandins in diabetic rats and restoration by insulin therapy.
    Sugimoto H; Kimura T; Wakasugi H; Ibayashi H
    Fukuoka Igaku Zasshi; 1982 Feb; 73(2):76-83. PubMed ID: 7047334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.